Huffman Jeff C., Pollack Mark H., Stern Theodore A.
Massachusetts General Hospital and McLean Hospital, Harvard Medical School, Boston, Mass.
Prim Care Companion J Clin Psychiatry. 2002 Apr;4(2):54-62. doi: 10.4088/pcc.v04n0203.
Approximately one quarter of patients who present to physicians for treatment of chest pain have panic disorder. Panic disorder frequently goes unrecognized and untreated among patients with chest pain, leading to frequent return visits and substantial morbidity. Panic attacks may lead to chest pain through a variety of mechanisms, both cardiac and noncardiac in nature, and multiple processes may cause chest pain in the same patient. Panic disorder is associated with elevated rates of cardiovascular diseases, including hypertension, cardiomyopathy, and, possibly, sudden cardiac death. Furthermore, patients with panic disorder and chest pain have high rates of functional disability and medical service utilization. Fortunately, panic disorder is treatable; selective serotonin reuptake inhibitors, benzodiazepines, and cognitive-behavioral psychotherapy all effectively reduce symptoms. Preliminary studies have also found that treatment of patients who have panic disorder and chest pain with benzodiazepines results in reduction of chest pain as well as relief of anxiety.
因胸痛症状就医的患者中,约四分之一患有惊恐障碍。在胸痛患者中,惊恐障碍常常未被识别和治疗,导致频繁复诊和严重发病。惊恐发作可通过多种机制引发胸痛,这些机制既有心脏方面的,也有非心脏方面的,而且同一患者的胸痛可能由多种过程导致。惊恐障碍与心血管疾病发病率升高有关,包括高血压、心肌病,甚至可能与心源性猝死有关。此外,患有惊恐障碍且伴有胸痛的患者功能残疾率和医疗服务利用率都很高。幸运的是,惊恐障碍是可治疗的;选择性5-羟色胺再摄取抑制剂、苯二氮䓬类药物和认知行为心理治疗都能有效减轻症状。初步研究还发现,用苯二氮䓬类药物治疗患有惊恐障碍且伴有胸痛的患者,可减轻胸痛并缓解焦虑。